Rosuvastatin for Preventing Complications in Renal Ablation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.
Also called NCT01899027
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 112 participants
- Registry
-
NCT01899027
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01899027. Randomized; single masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin for Preventing Complications in Renal Ablation
- Acronym
- ARTEMISIA
- Condition
- Arterial Hypertension
- Intervention (Drug)
- Rosuvastatin
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01899027- Content hash
4de5447f758c22c61de3d2386d0970f5e759104967f20eaa2209243337b76ac6